CTSO vs NIO · rev $18.5M vs rev $12.51B
Cytosorbents Crp (CTSO) versus Nio Inc Class A ADR (NIO) — a side-by-side from cached financials, not a winner call.
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US.
Latest reported CTSO revenue for 2026-06-30 was $18.5M. Net income was -$9.5M. CTSO currently screens at market cap $28.8M.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
CTSO currently screens at market cap $28.8M. NIO currently screens at market cap $7.61B.
Not investment advice. Open the CTSO and NIO stock pages for the full models.
Not investment advice.